GlassScriptPhysician profile
Jeness M Barthel
NPI 1588780795
$1,850.92
in general payments reported to CMS, 2019-2025
25 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $129 · 2021: $283 · 2022: $241 · 2023: $348 · 2024: $141 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.94 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $377.12 | 2019-2021 | |
| Astellas Pharma US INC | $272.25 | 2019-2024 | Veozah |
| Organon LLC | $151.72 | 2022-2025 | Nexplanon, Nuvaring |
| Coopersurgical, INC. | $149.04 | 2019-2024 | Mara Console, Paragard T 380a |
| Intuitive Surgical, INC. | $121.36 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.60 | 2019-2022 | |
| Pfizer INC. | $98.68 | 2019-2025 | |
| Baxter Healthcare | $74.50 | 2023-2025 | Tisseel, Perclot |
| Hologic Sales and Service, LLC | $65.01 | 2019-2025 | Myosure Tissue Removal Device |
| Therapeuticsmd, INC. | $60.69 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $52.98 | 2019-2022 | |
| Exeltis, USA INC. | $51.08 | 2022-2025 | Slynd |
| Davol INC. | $44.13 | 2023-2024 | Arista Ah Flexitip |
| Millicent US INC | $41.80 | 2025 | Femlyv, Femring, Intrarosa |
| Dysis Medical, INC. | $38.23 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $25.74 | 2020-2021 | |
| Medtronic, INC. | $20.12 | 2022 | |
| Boston Scientific Corporation | $19.77 | 2019 | |
| Aspira Women'S Health INC | $14.87 | 2021 | |
| Acessa Health INC. | $14.53 | 2020 | |
| Gynesonics, INC. | $13.04 | 2022 | |
| Allergan, INC. | $12.08 | 2019 | |
| Lupin INC. | $11.49 | 2020 | |
| Amgen INC. | $11.09 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeness Barthel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.